Big Pharma's Got One Toe In, At Least

genomeweb
360dx

Big Pharma's Got One Toe In, At Least

Oct 01, 2007

At VentureBeat, David Hamilton points to news reported in the New York Times of the establishment of the International Serious Adverse Events Consortium.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

Active Celiac Disease Processes Informed by Intestinal Expression Comparison
Amercian Cancer Society Philanthropic Fund BrightEdge Invests in Castle Bio
PetaGene Inks Reseller Agreement With NetApp
Pancreatic, Brain Development Gene Found From Patient Exomes
In Brief This Week: Agendia, Genomics Medicine Ireland, Zymo Research, and More
Danaher Q1 Revenues Up 4 Percent

The Scan

Same Scam, New Tech

Bloomberg reports that the DNA-for-cash deal reported in Kentucky might be a more widespread scam.

Gene Therapy for SCID-X1

St. Jude Children's Research Hospital scientists have treated infants with X-linked severe combined immunodeficiency using gene therapy in an early phase study.

To Guide the Genealogy Search

St. Louis Public Radio reports that some African Americans are turning to DNA ancestry testing to help guide genealogical searches.

This Week in Nature

In Nature this week: a genomic analysis of the snailfish Pseudoliparis swirei, ancient DNA analysis gives insight into the introduction of farming to England, and more.

Menu